|
1
|
Shi Y, Zhang Z, Qu X, Zhu X, Zhao L, Wei
R, Guo Q, Sun L, Yin X, Zhang Y and Li X: Roles of STAT3 in
leukemia (review). Int J Oncol. 53:7–20. 2018.PubMed/NCBI
|
|
2
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Shen Y, Wang S, Shen Q and Zhou X:
The role of STAT3 in leading the crosstalk between human cancers
and the immune system. Cancer Lett. 415:117–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen CL, Hsieh FC, Lieblein JC, Brown J,
Chan C, Wallace JA, Cheng G, Hall BM and Lin J: Stat3 activation in
human endometrial and cervical cancers. Br J Cancer. 96:591–599.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takemoto S, Ushijima K, Kawano K,
Yamaguchi T, Terada A, Fujiyoshi N, Nishio S, Tsuda N, Ijichi M,
Kakuma T, et al: Expression of activated signal transducer and
activator of transcription-3 predicts poor prognosis in cervical
squamous-cell carcinoma. Br J Cancer. 101:967–972. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shukla S, Shishodia G, Mahata S, Hedau S,
Pandey A, Bhambhani S, Batra S, Basir SF, Das BC and Bharti AC:
Aberrant expression and constitutive activation of STAT3 in
cervical carcinogenesis: Implications in high-risk human
papillomavirus infection. Mol Cancer. 9:2822010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shukla S, Mahata S, Shishodia G, Pandey A,
Tyagi A, Vishnoi K, Basir SF, Das BC and Bharti AC: Functional
regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.
PLoS One. 8:e678492013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yong L and Guang B: Intraperitoneal
ropivacaine instillation versus no intraperitoneal ropivacaine
instillation for laparoscopic cholecystectomy: A systematic review
and meta-analysis. Int J Surg. 44:229–243. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Oliveira GS Jr, Ahmad S, Schink JC,
Singh DK, Fitzgerald PC and McCarthy RJ: Intraoperative neuraxial
anesthesia but not postoperative neuraxial analgesia is associated
with increased relapse-free survival in ovarian cancer patients
after primary cytoreductive surgery. Reg Anesth Pain Med.
36:271–277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Biki B, Mascha E, Moriarty DC, Fitzpatrick
JM, Sessler DI and Buggy DJ: Anesthetic technique for radical
prostatectomy surgery affects cancer recurrence: A retrospective
analysis. Anesthesiology. 109:180–187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng Q, Peng X and Yu H: Local anesthetic
drug inhibits growth and survival in chronic myeloid leukemia
through suppressing PI3K/Akt/mTOR. Am J Med Sci. 355:266–273. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Le Gac G, Angenard G, Clément B, Laviolle
B, Coulouarn C and Beloeil H: Local anesthetics inhibit the growth
of human hepatocellular carcinoma cells. Anesth Analg.
125:1600–1609. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bundscherer A, Malsy M, Gebhardt K,
Metterlein T, Plank C, Wiese CH, Gruber M and Graf BM: Effects of
ropivacaine, bupivacaine and sufentanil in colon and pancreatic
cancer cells in vitro. Pharmacol Res. 95-96:126–131. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W, Cai J, Zhang H, Wang G and Jiang
W: Effects of lidocaine and ropivacaine on gastric cancer cells
through down-regulation of ERK1/2 phosphorylation in vitro.
Anticancer Res. 38:6729–6735. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Peng X and Zheng Q: Ropivacaine
inhibits the migration of esophageal cancer cells via
sodium-channel-independent but prenylation-dependent inhibition of
Rac1/JNK/paxillin/FAK. Biochem Biophys Res Commun. 501:1074–1079.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HW, Wang LY, Jiang L, Tian SM, Zhong
TD and Fang XM: Amide-linked local anesthetics induce apoptosis in
human non-small cell lung cancer. J Thorac Dis. 8:2748–2757. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiong A, Yang Z, Shen Y, Zhou J and Shen
Q: Transcription factor STAT3 as a novel molecular target for
cancer prevention. Cancers (Basel). 6:926–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du WW, Fang L, Li M, Yang X, Liang Y, Peng
C, Qian W, O'Malley YQ, Askeland RW, Sugg SL, et al: MicroRNA
miR-24 enhances tumor invasion and metastasis by targeting PTPN9
and PTPRF to promote EGF signaling. J Cell Sci. 126:1440–1453.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong Y, Liang H, Uzair-Ur-Rehman, Wang Y,
Zhang W, Zhou Y, Chen S, Yu M, Cui S, Liu M, et al: miR-96 promotes
cell proliferation, migration and invasion by targeting PTPN9 in
breast cancer. Sci Rep. 6:374212016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu J, Li H, Ma J, Huang H, Qin J and Li
Y: PTPN9 promotes cell proliferation and invasion in Eca109 cells
and is negatively regulated by microRNA-126. Oncol Lett.
14:1419–1426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Sun F, Hong Y, Liu Y, Fen M, Yin K,
Ge X, Wang F, Chen X and Guan W: MEG2 is regulated by miR-181a-5p
and functions as a tumour suppressor gene to suppress the
proliferation and migration of gastric cancer cells. Mol Cancer.
16:1332017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li WT, Wang BL, Yang CS, Lang BC and Lin
YZ: MiR-613 promotes cell proliferation and invasion in cervical
cancer via targeting PTPN9. Eur Rev Med Pharmacol Sci.
22:4107–4114. 2018.PubMed/NCBI
|
|
24
|
Cassinello F, Prieto I, del Olmo M, Rivas
S and Strichartz GR: Cancer surgery: How may anesthesia influence
outcome? J Clin Anesth. 27:262–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gong X, Dan J, Li F and Wang L:
Suppression of mitochondrial respiration with local anesthetic
ropivacaine targets breast cancer cells. J Thorac Dis.
10:2804–2812. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Piegeler T, Schläpfer M, Dull RO, Schwartz
DE, Borgeat A, Minshall RD and Beck-Schimmer B: Clinically relevant
concentrations of lidocaine and ropivacaine inhibit TNFα-induced
invasion of lung adenocarcinoma cells in vitro by blocking the
activation of Akt and focal adhesion kinase. Br J Anaesth.
115:784–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu YJ, Li SY, Cheng Q, Chen WK, Wang SL,
Ren Y and Miao CH: Effects of anaesthesia on proliferation,
invasion and apoptosis of LoVo colon cancer cells in vitro.
Anaesthesia. 71:147–154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li R, Xiao C, Liu H, Huang Y, Dilger JP
and Lin J: Effects of local anesthetics on breast cancer cell
viability and migration. BMC Cancer. 18:6662018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fan Z, Cui H, Xu X, Lin Z, Zhang X, Kang
L, Han B, Meng J, Yan Z, Yan X and Jiao S: MiR-125a suppresses
tumor growth, invasion and metastasis in cervical cancer by
targeting STAT3. Oncotarget. 6:25266–25280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Su F, Ren F, Rong Y, Wang Y, Geng Y, Wang
Y, Feng M, Ju Y, Li Y, Zhao ZJ, et al: Protein tyrosine phosphatase
Meg2 dephosphorylates signal transducer and activator of
transcription 3 and suppresses tumor growth in breast cancer.
Breast Cancer Res. 14:R382012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bu Y, Su F, Wang X, Gao H, Lei L, Chang N,
Wu Q, Hu K, Zhu X, Chang Z, et al: Protein tyrosine phosphatase
PTPN9 regulates erythroid cell development through STAT3
dephosphorylation in zebrafish. J Cell Sci. 127:2761–2770. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jung SN, Shin DS, Kim HN, Jeon YJ, Yun J,
Lee YJ, Kang JS, Han DC and Kwon BM: Sugiol inhibits STAT3 activity
via regulation of transketolase and ROS-mediated ERK activation in
DU145 prostate carcinoma cells. Biochem Pharmacol. 97:38–50. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang D, Cheng Z, Zhao M, Jiao C, Meng Q,
Pan H, Xie Y, Li L, Zhu Y, Wang W, et al: PTPN9 induces cell
apoptosis by mitigating the activation of Stat3 and acts as a tumor
suppressor in colorectal cancer. Cancer Manag Res. 11:1309–1319.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma X, Shi W, Peng L, Qin X and Hui Y:
MiR-96 enhances cellular proliferation and tumorigenicity of human
cervical carcinoma cells through PTPN9. Saudi J Biol Sci.
25:863–867. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu
C, Li J, Wang X and Song L: Unregulated miR-96 induces cell
proliferation in human breast cancer by downregulating
transcriptional factor FOXO3a. PLoS One. 5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Haflidadóttir BS, Larne O, Martin M,
Persson M, Edsjö A, Bjartell A and Ceder Y: Upregulation of miR-96
enhances cellular proliferation of prostate cancer cells through
FOXO1. PLoS One. 8:e724002013. View Article : Google Scholar : PubMed/NCBI
|
